UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 11, 2013
GLYECO, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
Nevada
|
000-30396
|
45-4030261
|
||
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
||
|
4802 East Ray Road, Suite 23-196
Phoenix, Arizona
|
85044
|
|||
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (866) 960-1539
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01 Regulation FD Disclosure.
The Company has retained its placement agent and has initiated a new offering that contains terms that are materially different than the terms of the Company’s previous offering. The Company’s new offering (the “Offering”) is for a purchase price of $0.65 per Unit. Each Unit consists of (i) one share of common stock, par value $0.001 per share, of the Company, and (ii) one warrant to purchase one share of common stock of the Company from the date of issuance until the third anniversary of such date for a purchase price of $1.25 per share. The Offering will be made to accredited investors only, in accordance with Rule 506 of Regulation D of the Securities Act of 1933. The Offering commences on January 11, 2013, and will close on February 28, 2013 or at such later date as may be determined by the Company.
The information contained herein shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the securities described herein, nor shall there be any sale of the Company’s securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities to be offered have not been registered under the Securities Act of 1933 or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This notice is being issued pursuant to and in accordance with Rule 135c under the Securities Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
GLYECO, INC.
|
||
|
Dated: January 11, 2013
|
By:
|
/s/ John Lorenz
|
|
John Lorenz
President and Chief Executive Officer, Director
(Principal Executive Officer)
|